Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Use to detect Blastomyces antibodies in CSF. For diagnosis of blastomycosis, consider testing in conjunction with histology or culture.
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
This test is not New York state approved. There are no New York state-approved laboratories available. Submit a Non-Permitted Laboratory Request Form (NPL) to the NYDOH prior to collection of specimen. If NPL is approved by NYDOH, and sample is received at ARUP, testing will be performed.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
CSF.
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Transfer 1 mL CSF to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Refrigerated.
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Other body fluids. Contaminated, hemolyzed, xanthochromic, or severely lipemic specimens.
RemarksAdditional specimen collection, transport, or test submission information.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
Expected turnaround time for a result, beginning when ARUP has received the specimen.
2-6 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Test Number
Components
Reference Interval
Blastomyces Antibodies EIA, CSF
0.9 IV or less
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
Component
Interpretation
Blastomyces Antibodies EIA, CSF
0.9 IV or less Negative 1.0-1.4 IV Equivocal 1.5 IV or greater Positive
Compliance Category
Modified FDA
Note
Additional information related to the test.
This immunoassay detects total antibodies against yeast-phase antigens from Blastomyces dermatitidis. If Blastomyces antibodies are equivocal or positive by immunoassay then Blastomyces dermatitidis Antibodies by Immunodiffusion will be added. Additional charges apply.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
Blastomyces dermatitidis, yeast-phase
Blastomycoses
Fungal meningitis
Precipitin
Blastomyces dermatitidis Antibodies by Immunoassay with Reflex to Immunodiffusion, CSF
Connect Sign In
